Association of Positive Airway Pressure With Cardiovascular Events and Death in Adults With Sleep Apnea: A Systematic Review and Meta-analysis | Cardiology | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.170.64.36. Please contact the publisher to request reinstatement.
1.
Marin  JM, Agusti  A, Villar  I,  et al.  Association between treated and untreated obstructive sleep apnea and risk of hypertension.  JAMA. 2012;307(20):2169-2176.PubMedGoogle ScholarCrossref
2.
Lavie  L.  Oxidative stress in obstructive sleep apnea and intermittent hypoxia—revisited—the bad ugly and good.  Sleep Med Rev. 2015;20:27-45.PubMedGoogle ScholarCrossref
3.
Phillips  CL, McEwen  BJ, Morel-Kopp  MC,  et al.  Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea.  Thorax. 2012;67(7):639-644.PubMedGoogle ScholarCrossref
4.
Somers  VK, White  DP, Amin  R,  et al.  Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing.  J Am Coll Cardiol. 2008;52(8):686-717.PubMedGoogle ScholarCrossref
5.
Buchanan  P, Grunstein  R. Positive airway pressure treatment for obstructive sleep apnea-hypopnea syndrome. In: Kryger  MH, Roth  T, Dement  WC In:  Principles and Practice of Sleep Medicine. 5th ed. Philadelphia, PA: Elsevier Saunders; 2011:1233-1249
6.
Guo  J, Sun  Y, Xue  LJ,  et al.  Effect of CPAP therapy on cardiovascular events and mortality in patients with obstructive sleep apnea.  Sleep Breath. 2016;20(3):965-974.PubMedGoogle ScholarCrossref
7.
Bratton  DJ, Gaisl  T, Wons  AM, Kohler  M.  CPAP vs mandibular advancement devices and blood pressure in patients with obstructive sleep apnea.  JAMA. 2015;314(21):2280-2293.PubMedGoogle ScholarCrossref
8.
Kernan  WN, Ovbiagele  B, Black  HR,  et al.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.  Stroke. 2014;45(7):2160-2236.PubMedGoogle ScholarCrossref
9.
Parra  O, Sánchez-Armengol  A, Bonnin  M,  et al.  Early treatment of obstructive apnoea and stroke outcome.  Eur Respir J. 2011;37(5):1128-1136.PubMedGoogle ScholarCrossref
10.
Minnerup  J, Ritter  MA, Wersching  H,  et al.  Continuous positive airway pressure ventilation for acute ischemic stroke.  Stroke. 2012;43(4):1137-1139.PubMedGoogle ScholarCrossref
11.
Brown  DL, Chervin  RD, Kalbfleisch  JD,  et al.  Sleep apnea treatment after stroke (SATS) trial.  J Stroke Cerebrovasc Dis. 2013;22(8):1216-1224.PubMedGoogle ScholarCrossref
12.
Liberati  A, Altman  DG, Tetzlaff  J,  et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions.  BMJ. 2009;339:b2700.PubMedGoogle ScholarCrossref
13.
Higgins  JPT, Green  S, eds.  Cochrane Handbook for Systematic Reviews of Interventions: Version 5.1.0. London, England: Cochrane Collaboration; 2011.
14.
Woodward  M.  Epidemiology: Study Design and Data Analysis. 2nd ed. New York, NY: CRC Press; 2005.
15.
Higgins  JP, Thompson  SG, Deeks  JJ, Altman  DG.  Measuring inconsistency in meta-analyses.  BMJ. 2003;327(7414):557-560.PubMedGoogle ScholarCrossref
16.
Bradley  TD, Logan  AG, Kimoff  RJ,  et al.  Continuous positive airway pressure for central sleep apnea and heart failure.  N Engl J Med. 2005;353(19):2025-2033.PubMedGoogle ScholarCrossref
17.
Barbé  F, Durán-Cantolla  J, Sánchez-de-la-Torre  M,  et al.  Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea.  JAMA. 2012;307(20):2161-2168.PubMedGoogle ScholarCrossref
18.
Craig  SE, Kohler  M, Nicoll  D,  et al.  Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea.  Thorax. 2012;67(12):1090-1096.PubMedGoogle ScholarCrossref
19.
Kushida  CA, Nichols  DA, Holmes  TH,  et al.  Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients.  Sleep. 2012;35(12):1593-1602.PubMedGoogle ScholarCrossref
20.
McMillan  A, Bratton  DJ, Faria  R,  et al.  Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT).  Lancet Respir Med. 2014;2(10):804-812.PubMedGoogle ScholarCrossref
21.
Cowie  MR, Woehrle  H, Wegscheider  K,  et al.  Adaptive servo-ventilation for central sleep apnea in systolic heart failure.  N Engl J Med. 2015;373(12):1095-1105.PubMedGoogle ScholarCrossref
22.
Huang  Z, Liu  Z, Luo  Q,  et al.  Long-term effects of continuous positive airway pressure on blood pressure and prognosis in hypertensive patients with coronary heart disease and obstructive sleep apnea.  Am J Hypertens. 2015;28(3):300-306.PubMedGoogle ScholarCrossref
23.
Parra  O, Sánchez-Armengol  Á, Capote  F,  et al.  Efficacy of continuous positive airway pressure treatment on 5-year survival in patients with ischaemic stroke and obstructive sleep apnea.  J Sleep Res. 2015;24(1):47-53.PubMedGoogle ScholarCrossref
24.
McEvoy  RD, Antic  NA, Heeley  E,  et al.  CPAP for prevention of cardiovascular events in obstructive sleep apnea.  N Engl J Med. 2016;375(10):919-931.PubMedGoogle ScholarCrossref
25.
Peker  Y, Glantz  H, Eulenburg  C, Wegscheider  K, Herlitz  J, Thunström  E.  Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea.  Am J Respir Crit Care Med. 2016;194(5):613-620.PubMedGoogle ScholarCrossref
26.
Hoyos  CM, Yee  BJ, Wong  KK, Grunstein  RR, Phillips  CL.  Treatment of sleep apnea with CPAP lowers central and peripheral blood pressure independent of the time-of-day.  Am J Hypertens. 2015;28(10):1222-1228.PubMedGoogle ScholarCrossref
27.
Lozano  L, Tovar  JL, Sampol  G,  et al.  Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension.  J Hypertens. 2010;28(10):2161-2168.PubMedGoogle ScholarCrossref
28.
Martínez-García  MA, Capote  F, Campos-Rodríguez  F,  et al.  Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension.  JAMA. 2013;310(22):2407-2415.PubMedGoogle ScholarCrossref
29.
Gottlieb  DJ, Punjabi  NM, Mehra  R,  et al.  CPAP versus oxygen in obstructive sleep apnea.  N Engl J Med. 2014;370(24):2276-2285.PubMedGoogle ScholarCrossref
30.
Chirinos  JA, Gurubhagavatula  I, Teff  K,  et al.  CPAP, weight loss, or both for obstructive sleep apnea.  N Engl J Med. 2014;370(24):2265-2275.PubMedGoogle ScholarCrossref
31.
Lacasse  Y, Godbout  C, Sériès  F.  Independent validation of the Sleep Apnoea Quality of Life Index.  Thorax. 2002;57(6):483-488.PubMedGoogle ScholarCrossref
32.
Ryan  CM, Bayley  M, Green  R, Murray  BJ, Bradley  TD.  Influence of continuous positive airway pressure on outcomes of rehabilitation in stroke patients with obstructive sleep apnea.  Stroke. 2011;42(4):1062-1067.PubMedGoogle ScholarCrossref
33.
Povitz  M, Bolo  CE, Heitman  SJ, Tsai  WH, Wang  J, James  MT.  Effect of treatment of obstructive sleep apnea on depressive symptoms.  PLoS Med. 2014;11(11):e1001762.PubMedGoogle ScholarCrossref
34.
Batool-Anwar  S, Goodwin  JL, Kushida  CA,  et al.  Impact of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea (OSA).  J Sleep Res. 2016;25(6):731-738.PubMedGoogle ScholarCrossref
35.
Campos-Rodriguez  F, Queipo-Corona  C, Carmona-Bernal  C,  et al.  Continuous positive airway pressure improves quality of life in women with obstructive sleep apnea.  Am J Respir Crit Care Med. 2016;194(10):1286-1294.PubMedGoogle ScholarCrossref
36.
Piepoli  MF, Hoes  AW, Agewall  S,  et al.  2016 European Guidelines on cardiovascular disease prevention in clinical practice.  Eur Heart J. 2016;37(29):2315-2381.PubMedGoogle ScholarCrossref
37.
Qaseem  A, Holty  JE, Owens  DK, Dallas  P, Starkey  M, Shekelle  P.  Management of obstructive sleep apnea in adults.  Ann Intern Med. 2013;159(7):471-483.PubMedGoogle Scholar
38.
Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel members.  An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia—full report.  J Clin Lipidol. 2014;8(1):29-60.PubMedGoogle ScholarCrossref
39.
Young  T, Palta  M, Dempsey  J, Skatrud  J, Weber  S, Badr  S.  The occurrence of sleep-disordered breathing among middle-aged adults.  N Engl J Med. 1993;328(17):1230-1235.PubMedGoogle ScholarCrossref
40.
Quan  SF, Howard  BV, Iber  C,  et al.  The Sleep Heart Health Study: design, rationale, and methods.  Sleep. 1997;20(12):1077-1085.PubMedGoogle Scholar
41.
Bixler  EO, Vgontzas  AN, Lin  HM,  et al.  Prevalence of sleep-disordered breathing in women.  Am J Respir Crit Care Med. 2001;163(3 Pt 1):608-613.PubMedGoogle ScholarCrossref
42.
Peppard  PE, Young  T, Barnet  JH, Palta  M, Hagen  EW, Hla  KM.  Increased prevalence of sleep-disordered breathing in adults.  Am J Epidemiol. 2013;177(9):1006-1014.PubMedGoogle ScholarCrossref
43.
Heinzer  R, Vat  S, Marques-Vidal  P,  et al.  Prevalence of sleep-disordered breathing in the general population.  Lancet Respir Med. 2015;3(4):310-318.PubMedGoogle ScholarCrossref
44.
Pataka  A, Riha  RL.  Continuous positive airway pressure and cardiovascular events in patients with obstructive sleep apnea.  Curr Cardiol Rep. 2013;15(8):385.PubMedGoogle ScholarCrossref
45.
Pack  AI, Gislason  T.  Obstructive sleep apnea and cardiovascular disease.  Prog Cardiovasc Dis. 2009;51(5):434-451.PubMedGoogle ScholarCrossref
46.
Drager  LF, Brunoni  AR, Jenner  R, Lorenzi-Filho  G, Benseñor  IM, Lotufo  PA.  Effects of CPAP on body weight in patients with obstructive sleep apnoea.  Thorax. 2015;70(3):258-264.PubMedGoogle ScholarCrossref
47.
Peppard  PE, Young  T, Palta  M, Dempsey  J, Skatrud  J.  Longitudinal study of moderate weight change and sleep-disordered breathing.  JAMA. 2000;284(23):3015-3021.PubMedGoogle ScholarCrossref
48.
Barbé  F, Durán-Cantolla  J, Capote  F,  et al.  Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea.  Am J Respir Crit Care Med. 2010;181(7):718-726.PubMedGoogle ScholarCrossref
49.
Martínez-Cerón  E, Barquiel  B, Bezos  AM,  et al.  Effect of continuous positive airway pressure on glycemic control in patients with obstructive sleep apnea and type 2 diabetes.  Am J Respir Crit Care Med. 2016;194(4):476-485.PubMedGoogle ScholarCrossref
50.
Schwarz  EI, Puhan  MA, Schlatzer  C, Stradling  JR, Kohler  M.  Effect of CPAP therapy on endothelial function in obstructive sleep apnoea.  Respirology. 2015;20(6):889-895.PubMedGoogle ScholarCrossref
51.
Iftikhar  IH, Hoyos  CM, Phillips  CL, Magalang  UJ.  Meta-analyses of the association of sleep apnea with insulin resistance, and the effects of CPAP on HOMA-IR, adiponectin, and visceral adipose fat.  J Clin Sleep Med. 2015;11(4):475-485.PubMedGoogle Scholar
52.
Feng  Y, Zhang  Z, Dong  ZZ.  Effects of continuous positive airway pressure therapy on glycaemic control, insulin sensitivity and body mass index in patients with obstructive sleep apnoea and type 2 diabetes.  NPJ Prim Care Respir Med. 2015;25:15005.PubMedGoogle ScholarCrossref
53.
Mihaylova  B, Emberson  J, Blackwell  L,  et al.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease.  Lancet. 2012;380(9841):581-590.PubMedGoogle ScholarCrossref
54.
Stone  NJ, Robinson  JG, Lichtenstein  AH,  et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults.  Circulation. 2014;129(25)(suppl 2):S1-S45.PubMedGoogle ScholarCrossref
55.
Sundström  J, Arima  H, Jackson  R,  et al.  Effects of blood pressure reduction in mild hypertension.  Ann Intern Med. 2015;162(3):184-191.PubMedGoogle ScholarCrossref
56.
Sundström  J, Arima  H, Woodward  M,  et al.  Blood pressure-lowering treatment based on cardiovascular risk.  Lancet. 2014;384(9943):591-598.PubMedGoogle ScholarCrossref
57.
Baigent  C, Blackwell  L, Collins  R,  et al.  Aspirin in the primary and secondary prevention of vascular disease.  Lancet. 2009;373(9678):1849-1860.PubMedGoogle ScholarCrossref
58.
Quan  SF, Budhiraja  R, Clarke  DP,  et al.  Impact of treatment with continuous positive airway pressure (CPAP) on weight in obstructive sleep apnea.  J Clin Sleep Med. 2013;9(10):989-993.PubMedGoogle Scholar
Original Investigation
July 11, 2017

Association of Positive Airway Pressure With Cardiovascular Events and Death in Adults With Sleep Apnea: A Systematic Review and Meta-analysis

Author Affiliations
  • 1Department of Cardiology, Peking University Third Hospital, Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Beijing, People’s Republic of China
  • 2The George Institute for Global Health, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia
  • 3Department of Radiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China
  • 4Adelaide Institute for Sleep Health, Flinders University, Adelaide, South Australia, Australia
  • 5The George Institute China, Peking University Health Science Center, Beijing, People’s Republic of China
  • 6Neurology Department, Royal Prince Alfred Hospital, Sydney Health Partners, Sydney, New South Wales, Australia
  • 7The Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia
  • 8Division of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom
JAMA. 2017;318(2):156-166. doi:10.1001/jama.2017.7967
Key Points

Question  Does the use of positive airway pressure (PAP) to treat sleep apnea reduce risk of cardiovascular events and death?

Findings  In this meta-analysis of 10 randomized clinical trials including 7266 patients, there was no significant association of PAP compared with no treatment (or sham PAP) on a composite outcome of acute coronary syndrome events, stroke, or vascular death (relative risk, 0.77 [95% CI, 0.53-1.13]). There was also no significant association with individual outcomes or all-cause death.

Meaning  Although there are other benefits of PAP use for treating sleep apnea, these findings do not support treatment with a goal of preventing cardiovascular outcomes or improving survival.

Abstract

Importance  Sleep apnea (obstructive and central) is associated with adverse cardiovascular risk factors and increased risks of cardiovascular disease. Positive airway pressure (PAP) provides symptomatic relief, whether delivered continuously (CPAP) or as adaptive servo-ventilation (ASV), but the associations with cardiovascular outcomes and death are unclear.

Objective  To assess the association of PAP vs control with cardiovascular events and death in patients with sleep apnea.

Data Sources and Study Selection  MEDLINE, EMBASE, and the Cochrane Library were systematically searched from inception date to March 2017 for randomized clinical trials that included reporting of major adverse cardiovascular events or deaths.

Data Extraction and Synthesis  Two authors independently extracted data using standardized forms. Summary relative risks (RRs), risk differences (RDs) and 95% CIs were obtained using random-effects meta-analysis.

Main Outcomes and Measures  The main outcomes were a composite of acute coronary syndrome (ACS) events, stroke, or vascular death (major adverse cardiovascular events); cause-specific vascular events; and death.

Results  The analyses included data from 10 trials (9 CPAP; 1 ASV) of patients with sleep apnea (N = 7266; mean age, 60.9 [range, 51.5 to 71.1] years; 5847 [80.5%] men; mean [SD] body mass index, 30.0 [5.2]. Among 356 major adverse cardiovascular events and 613 deaths recorded, there was no significant association of PAP with major adverse cardiovascular events (RR, 0.77 [95% CI, 0.53 to 1.13]; P = .19 and RD, −0.01 [95% CI, −0.03 to 0.01]; P = .23), cardiovascular death (RR, 1.15 [95% CI, 0.88 to 1.50]; P = .30 and RD −0.00 [95% CI, −0.02 to 0.02]; P = .87), or all-cause death (RR, 1.13 [95% CI, 0.99 to 1.29]; P = .08 and RD, 0.00 [95% CI, −0.01 to 0.01]; P = .51). The same was true for ACS, stroke, and heart failure. There was no evidence of different associations for CPAP vs ASV (all P value homogeneity >.24), and meta-regressions identified no associations of PAP with outcomes for different levels of apnea severity, follow-up duration, or adherence to PAP (all P values > .13).

Conclusions and Relevance  The use of PAP, compared with no treatment or sham, was not associated with reduced risks of cardiovascular outcomes or death for patients with sleep apnea. Although there are other benefits of treatment with PAP for sleep apnea, these findings do not support treatment with PAP with a goal of prevention of these outcomes.

×